These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34729477)

  • 1. K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.
    Schoeler NE; Orford M; Vivekananda U; Simpson Z; Van de Bor B; Smith H; Balestrini S; Rutherford T; Brennan E; McKenna J; Lambert B; Barker T; Jackson R; Williams RSB; Sisodiya SM; Eaton S; Heales SJR; Cross JH; Walker MC;
    Brain Commun; 2021; 3(4):fcab160. PubMed ID: 34729477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance, adherence, and acceptability of a ketogenic 2.5:1 ratio, nutritionally complete, medium chain triglyceride-containing liquid feed in children and adults with drug-resistant epilepsy following a ketogenic diet.
    Griffen C; Schoeler NE; Browne R; Cameron T; Kirkpatrick M; Thowfeek S; Munn J; Champion H; Mills N; Phillips S; Air L; Devlin A; Nicol C; Macfarlane S; Bittle V; Thomas P; Cooke L; Ackril J; Allford A; Appleyard V; Szwec C; Atwal K; Hubbard GP; Stratton RJ
    Epilepsia Open; 2024 Apr; 9(2):727-738. PubMed ID: 38411329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies.
    Han FY; Conboy-Schmidt L; Rybachuk G; Volk HA; Zanghi B; Pan Y; Borges K
    Epilepsia; 2021 Aug; 62(8):1790-1806. PubMed ID: 34169513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response.
    Schoeler NE; Wood S; Aldridge V; Sander JW; Cross JH; Sisodiya SM
    Epilepsy Behav; 2014 Aug; 37():77-81. PubMed ID: 25010319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low glycemic index diet therapy (LGIT) in children aged 2-8 years with drug-resistant epilepsy: A randomized controlled trial.
    Lakshminarayanan K; Agarawal A; Panda PK; Sinha R; Tripathi M; Pandey RM; Gulati S
    Epilepsy Res; 2021 Mar; 171():106574. PubMed ID: 33582533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.
    Law TH; Davies ES; Pan Y; Zanghi B; Want E; Volk HA
    Br J Nutr; 2015 Nov; 114(9):1438-47. PubMed ID: 26337751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplification of Dietary Treatment in Pharmacoresistant Epilepsy: Impact of C8 and C10 Fatty Acids on Sirtuins of Neuronal Cells In Vitro.
    Rühling MR; Hartmann H; Das AM
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenic diet and other dietary treatments for epilepsy.
    Martin K; Jackson CF; Levy RG; Cooper PN
    Cochrane Database Syst Rev; 2016 Feb; 2():CD001903. PubMed ID: 26859528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketonuria and Seizure Control in the Medium Chain Triglyceride and Classic Ketogenic Diets.
    Lowe H; Keller AE; Tanzini E; Aimola S; Liu YMC; Zak M; Chan V; Kobayashi J; Donner EJ
    Can J Neurol Sci; 2022 May; 49(3):433-436. PubMed ID: 34075859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges.
    Cervenka MC; Henry BJ; Felton EA; Patton K; Kossoff EH
    Epilepsy Behav; 2016 May; 58():61-8. PubMed ID: 27060389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of a whey-based, medium-chain triglyceride-enhanced ketogenic formula in children with refractory epilepsy: A retrospective study.
    Wheeler CE; Temkit M; Wilfong AA; Vanatta L; Jarrar R
    Seizure; 2021 Oct; 91():29-33. PubMed ID: 34058606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic diet and other dietary treatments for epilepsy.
    Levy RG; Cooper PN; Giri P
    Cochrane Database Syst Rev; 2012 Mar; (3):CD001903. PubMed ID: 22419282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
    Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
    CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells.
    Hughes SD; Kanabus M; Anderson G; Hargreaves IP; Rutherford T; O'Donnell M; Cross JH; Rahman S; Eaton S; Heales SJ
    J Neurochem; 2014 May; 129(3):426-33. PubMed ID: 24383952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Hydroxybutyrate and Medium-Chain Fatty Acids are Metabolized by Different Cell Types in Mouse Cerebral Cortex Slices.
    Andersen JV; Westi EW; Neal ES; Aldana BI; Borges K
    Neurochem Res; 2023 Jan; 48(1):54-61. PubMed ID: 35999339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.
    Neal EG; Chaffe H; Schwartz RH; Lawson MS; Edwards N; Fitzsimmons G; Whitney A; Cross JH
    Lancet Neurol; 2008 Jun; 7(6):500-6. PubMed ID: 18456557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cooking oils in a 2:1 ratio classical ketogenic diet for intractable pediatric epilepsy: Long-term effectiveness and tolerability.
    Lee HF; Chi CS; Liao JH
    Epilepsy Res; 2018 Nov; 147():75-79. PubMed ID: 30273790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet.
    Khabbush A; Orford M; Tsai YC; Rutherford T; O'Donnell M; Eaton S; Heales SJR
    Epilepsia; 2017 Aug; 58(8):1423-1429. PubMed ID: 28682459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial.
    Kverneland M; Molteberg E; Iversen PO; Veierød MB; Taubøll E; Selmer KK; Nakken KO
    Epilepsia; 2018 Aug; 59(8):1567-1576. PubMed ID: 29901816
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.